Evidence map›Paper›PMID 29615738›Full record

ArticleScientific reports2018

Abundant fish protein inhibits α-synuclein amyloid formation.

Tony Werner, Ranjeet Kumar, Istvan Horvath, Nathalie Scheers, Pernilla Wittung-Stafshede

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Biological Amyloids Chemically Damage DNA.ACS chemical neuroscience · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Microbiome Impact on Amyloidogenesis.Frontiers in molecular biosciences · 2022
    Review
  11. Article
  12. Article
  13. Amyloid formation of fish β-parvalbumin involves primary nucleation triggered by disulfide-bridged protein dimers.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Differential effects of CuBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2020
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tony WernerDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Ranjeet KumarDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Istvan HorvathDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Nathalie ScheersDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.ORCID 0000-0001-8812-9025
Pernilla Wittung-StafshedeDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden. Pernilla.wittung@chalmers.se.ORCID 0000-0003-1058-1964
Chalmers University of Technology · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common allergen in fish, the highly-abundant protein β-parvalbumin, forms amyloid structures as a way to avoid gastrointestinal degradation and transit to the blood. In humans, the same amyloid structures are mostly associated with neurodegenerative disorders such as Alzheimer's and Parkinson's. We here assessed a putative connection between these amyloids using recombinant Atlantic cod β-parvalbumin and the key amyloidogenic protein in Parkinson's disease, α-synuclein. Using a set of in vitro biophysical methods, we discovered that β-parvalbumin readily inhibits amyloid formation of α-synuclein. The underlying mechanism was found to involve α-synuclein binding to the surface of β-parvalbumin amyloid fibers. In addition to being a new amyloid inhibition mechanism, the data suggest that health benefits of fish may be explained in part by cross-reaction of β-parvalbumin with human amyloidogenic proteins.

Indexed as

alpha-SynucleinAmyloidFish ProteinsHealthHumansProtein MultimerizationProtein Structure, Secondaryalpha-SynucleinAmyloidFish Proteins

Identifiers

PMID29615738
PMCPMC5882657
OpenAlexW2795490481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.